Article Versions Notes

Chuang Y-H, Lee C-H, Lin C-Y, Liu C-L, Huang S-H, Lee J-Y, Chiu Y-Y, Lee J-C, Yang J-M. An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer. Cancers. 2020; 12(5):1324. https://doi.org/10.3390/cancers12051324

Chuang, Yi-Hsuan, Chia-Hwa Lee, Chun-Yu Lin, Chia-Lin Liu, Sing-Han Huang, Jung-Yu Lee, Yi-Yuan Chiu, Jih-Chin Lee, and Jinn-Moon Yang. 2020. "An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer" Cancers 12, no. 5: 1324. https://doi.org/10.3390/cancers12051324

Chuang, Y.-H., Lee, C.-H., Lin, C.-Y., Liu, C.-L., Huang, S.-H., Lee, J.-Y., Chiu, Y.-Y., Lee, J.-C., & Yang, J.-M. (2020). An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer. Cancers, 12(5), 1324. https://doi.org/10.3390/cancers12051324